Physician Workflow study: OPA
Official title Evaluating a Our Practice Advisory (OPA) to Optimize Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH) Test Orders
ClinicalTrials.gov ID: NCT06993805
What this study is testing
- What it's testing
- The study wants to see if the alert changes doctors' test‑ordering habits and reduces repeat testing that rarely adds new information.
- Who it's for
- Doctors who order blood tests for diabetes (A1c) or thyroid (TSH) in the health system.
- What's involved
- When a doctor tries to order a repeat A1c or TSH test within 30 days, an on‑screen advisory appears suggesting it may not be needed. The study records whether the doctor follows the advice.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- 18 years or older
- Inpatient or observation stays within UCLA Health System hospitals
- Hemoglobin A1c (A1c) and Thyroid-Stimulating Hormone (TSH) ordered, AND this lab was ordered and resulted within the prior 30 days
You likely can't join if
- Have an A1c or TSH ordered and do not have a result for one of these labs in the prior 30 days
The study team makes the final eligibility decision.
Where it is enrolling
- Los Angeles, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Los Angeles, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.